Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction

Paola Secchiero, Federica Corallini, Claudio Ceconi et al. · 2009

Read Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction by Paola Secchiero, Federica Corallini, Claudio Ceconi et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004442.txt.

Description

A blood protein called TRAIL may help predict how heart attack patients fare, report Paola Secchiero, Federica Corallini, Claudio Ceconi, and co-authors in PLOS ONE in 2009. In lab and animal work, the soluble form of TRAIL calms inflammation and slows artery disease. That made it a candidate marker worth testing in real patients.

The team measured TRAIL levels in the blood of people who had just had a heart attack. They then compared those levels with how the patients did afterward. As the title signals, lower levels after the attack carried a poor outlook. A simple blood test that flags high-risk patients early could help doctors aim closer care at those who need it most.

Catalog record

CREATORPaola Secchiero, Federica Corallini, Claudio Ceconi et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004442

Browse the full library · About the Tower of Babel